Thursday, August 8, 2013

Torts Today: Generic drug mfrs should have same safety warning duty as brand name patentees - New England Journal of Medicine

A change in FDA policy could effectively remove Mutual Pharmaceutical v. Bartlett's immunization of generic drug manufacturers.
Torts Today: Generic drug mfrs should have same safety warning duty as brand name patentees - New England Journal of Medicine:

'via Blog this'

No comments:

Post a Comment